A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/199, 167/228
A61K 31/70 (2006.01) A61K 31/13 (2006.01) A61K 31/34 (2006.01) A61K 31/38 (2006.01) A61K 31/44 (2006.01)
Patent
CA 1336072
A pharmaceutical composition for the treatment of hyperammonemia which comprises a valiolamine compound of the formula Image [I] wherein A means an acyclic hydrocarbon group of 1 to 10 carbon atoms which may optionally be substituted by hydroxy, phenoxy, thienyl, furyl, pyridyl, cyclohexyl or optionally substituted phenyl; a 5- or 6-membered cyclic hydrocarbon group which may optionally be substituted by hydroxy, hydroxymethyl, methyl or amino; or a saccharide residue or a pharmaceutically acceptable salt thereof, the use of said valiolamine compound of the formula [I] or a pharmaceutically acceptable salt thereof in the preparation of a medicine for the treatment of hyperammonemia, and a method for the treatment of hyperammonemia which comprises administrating a valiolamine compound of the formula [I] or a pharmaceutically acceptable salt thereof.
600944
Esquivel Misael Uribe
Matsuo Takao
Nakamura Nobuto
Satoh Hiroshi
Fetherstonhaugh & Co.
Takeda Chemical Industries Ltd.
LandOfFree
Therapeutic composition for hepatic encephalopathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic composition for hepatic encephalopathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic composition for hepatic encephalopathy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1239125